1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Establishment and Characterization of Innovative Immunoreagents for Diagnosis of Neurodegenerative Disease
(
- Master (Two yrs)
-
Mark
Exploring the potential of saruparib in overcoming venetoclax resistance in AML
(
- Master (Two yrs)
-
Mark
Diversity of Human Allergen-Specific IgE and Defining Epitope Recognition of Allergic Subjects that are to Undergo Allergen-Specific Immunotherapy
(
- Master (Two yrs)
-
Mark
Assay optimization for spatial omics analysis of oropharyngeal cancer tissue
(
- Master (Two yrs)
-
Mark
Towards Establishment of an Ex Vivo Bladder Tumor Model using Precision Cut Tumor Slices (PCTS) for Evaluation of Existing and Novel Treatments
(
- Master (Two yrs)
-
Mark
Prognostic impact of CD163 and CD11c in B cell lymphomas
(
- Master (Two yrs)
- 2023
-
Mark
Investigations of immune population subsets in bladder cancer
(
- Master (Two yrs)
-
Mark
Estimation of immune infiltration in tumours using proteomics data
(
- Master (Two yrs)
-
Mark
Palmitoylation of transforming growth factor-ß receptor-I by ZDHHCs
(
- Master (Two yrs)
-
Mark
Evaluating targeted combination therapies in EGFR wild-type non-small-cell lung cancer using mass spectrometry-based proteomics
(
- Master (Two yrs)